BREAKING
Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS 1 minute ago Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8% 18 minutes ago BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit 36 minutes ago HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 2 hours ago Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates 2 hours ago Broadwind Energy Inc (BWEN) Reports Q4 Earnings 3 hours ago ATRenew Inc (RERE) Reports Q4 Earnings 3 hours ago Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings 3 hours ago SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10% 3 hours ago Groupon Inc. (GRPN) Misses Q4 EPS Estimates 3 hours ago Figure Technology (FIGR) Shares Surge 21% Despite Missing Q4 EPS 1 minute ago Dyne Therapeutics (DYN) Q4 Loss Narrows to $0.73/Share vs $0.76 Estimate, Shares Surge 11.8% 18 minutes ago BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit 36 minutes ago HPE Maintains $0.14 Quarterly Dividend With 2.61% Yield; Ex-Dividend Date March 24, 2026 2 hours ago Sprinklr Inc (CXM) Beats Q4 FY26 EPS Estimates 2 hours ago Broadwind Energy Inc (BWEN) Reports Q4 Earnings 3 hours ago ATRenew Inc (RERE) Reports Q4 Earnings 3 hours ago Pangaea Logistics Solutions Ltd (PANL) Reports Q4 Earnings 3 hours ago SolarEdge (SEDG) Q4 Loss Narrows to $0.14/Share vs $0.24 Estimate, Stock Jumps 10% 3 hours ago Groupon Inc. (GRPN) Misses Q4 EPS Estimates 3 hours ago
ADVERTISEMENT
BMY

Bristol-Myers Squibb Company

$BMY NYSE Feb 17, 2026 All Day FY 2026

Investor Toolbox

Listen to Call

Recording not yet available.

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

BMY Coverage

News BioNTech (BNTX) Reports Q4 Loss of EUR0.33/Share as COVID Vaccine Revenue Plunges; Founders Exit Mar 11, 2026 Event Bristol-Myers Squibb Company (BMY) Bristol Myers Squibb Announces Positive Phase 3 Results from the SUCCESSOR-2 Study of Oral Mezigdomide in Relapsed or Refractory Multiple Myeloma Mar 9, 2026 Event Bristol-Myers Squibb Company (BMY) U.S. FDA Approves Bristol Myers Squibb’s Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Mar 7, 2026 Event Bristol-Myers Squibb Company (BMY) Dividend Update Mar 2, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers Oct 30, 2025 News Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers Jul 31, 2025